Breast, new hope for more aggressive cancers

IN THE WORLD of oncology, what has just ended is probably the most important week of the year. These are “the days of Asco”, the congress from which research is expected to change clinical practice and to open new perspectives for the treatment of cancer. A “sacred” appointment certainly for doctors and for Big Pharma. But to which patients also look.